Erlotinib (Tarceva) experience in a public health system, minority patient population with progressive metastatic non-small cell lung cancer (mNSCLC)

被引：0
|
作者：
Nathan, Sunita [1 ]
Patel, Pritesh [1 ]
Sharma, Jennifer [1 ]
Samuel, Joyce [1 ]
Stroger, John H., Jr. [1 ]
机构：
[1] Cook Cty Hosp, Chicago, IL USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：588S / 589S
页数：2
相关论文
共 50 条
  • [31] Reviewing the safety of erlotinib in non-small cell lung cancer
    Reck, Martin
    Mok, Tony
    Wolf, Juergen
    Heigener, David
    Wu, Yi-long
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 147 - 157
  • [32] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
  • [33] Blood Cell Count Ratios at Diagnosis as Prognostic Markers in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)
    Ricardo, Eliza
    Boneti, Bianca
    Ribeiro, Taynan
    De Moraes, Rafael
    Freitas, Helano
    Da Costa, Alexandre
    Andrade, Victor
    De Lime, Vladmir Cordeiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S970 - S971
  • [34] IMPACT OF ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (A/MNSCLC) ON PATIENTS IN THE US AND UK: SURVEY RESULTS
    Tapan, U.
    Wang, Y.
    Meng, Y.
    Yang, H.
    Shah, M.
    Bell, K.
    Liao, A.
    Ye, M.
    Solem, C.
    VALUE IN HEALTH, 2024, 27 (06) : S335 - S335
  • [35] Erlotinib in Advanced Non-small Cell Lung Cancer Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study
    Reck, Martin
    van Zandwijk, Nico
    Gridelli, Cesare
    Baliko, Zoltan
    Rischin, Danny
    Allan, Simon
    Krzakowski, Maciej
    Heigener, David
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1616 - 1622
  • [36] Erlotinib induced fatal interstitial lung disease in a patient with metastatic non-small cell lung cancer: case report and review of literature
    Mangla, Ankit
    Agarwal, Nikki
    Carmel, Chou
    Lad, Thomas
    RARE TUMORS, 2016, 8 (03) : 130 - 133
  • [37] Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Elderly Patients: Survival Analysis Based on Platinum Retreatment
    Linsalmeida, T.
    Fernandes, R.
    Faccio, A.
    Reis Filho, P.
    Oliveira, H.
    Tavares, F.
    Peria, F.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S310 - S310
  • [38] ERLOTINIB in Second Line Treatment of Metastatic Lung Cancer: About 20 Case of Non-Small Cell LUNG
    Teyar, Nahla
    Bensaou, Malika Gamaz
    Bouzid, Kamel
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1498 - S1499
  • [39] Initial experience with erlotinib in advanced non-small cell lung cancer in the Kingdom of Saudi Arabia
    Alolayan, A. A. M.
    Musaad, S.
    Bamefleh, H.
    Nounou, M.
    Jazieh, A. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer
    Atmaca, Akin
    Al-Batran, Salah-Eddin
    Allgaeuer, Michael
    Jaeger, Elke
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (05) : 262 - +
12345